Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.
Overview and Management
Establishment Year
2005
Mission
To support ambitious entrepreneurs in building internationally scalable companies through capital, extensive experience, and technological expertise.
Values
Transparency, trust, respect, integrity, high ethical standards, and long-term partnerships.
Investment Roles
General Partner (GP)
Participant Demographics
Focuses on scale-up companies in the Netherlands and Colombia with recurring revenues of at least €1M (€500K in LATAM) and high annual growth rates.
Generational Wealth Planning
Risk Tolerance
Moderate risk tolerance with a focus on creating value through strategic exits.
References or Case Studies
Can provide case studies of past investments and exits, including CoolGames, Scarlet, and Versatel.
Team Experience
Over 30 years of venture capital and entrepreneurial experience.
Notable Achievements
Over 100 investments, more than 50 successful exits, including IPOs and strategic sales.
Project Track Record
Investments in CoolGames, Scarlet, Versatel, and others.
Exit Strategies
Strategic sales, IPOs, and acquisitions.
Legal, Compliance and Contact Information
Regulatory Registrations
Dutch Authority Financial Markets (AFM)
Compliance History
No major violations.
deals@solidventures.nl
Phone Number
Address
Amsterdam Netherlands
Similar Investor Firms
Frequently Asked Questions
How would you describe Solid Ventures?
Solid Ventures is a venture capital firm that focuses on investing in early-stage technology companies. They typically target sectors such as software, fintech, and digital health, aiming to support innovative startups with growth potential.
What is the total value of assets managed by Solid Ventures?
As of October 2023, Solid Ventures manages approximately $2.5 billion in assets.
Which assets or companies are included in Solid Ventures’s investment portfolio?
As of October 2023, Solid Ventures's investment portfolio includes a range of technology and healthcare companies, though specific names and figures are not publicly disclosed. For the most accurate and up-to-date information, it is advisable to refer to their official reports or announcements.